Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
156.9 USD | -6.54% | -8.08% | -12.84% |
May. 21 | Glenmark Pharma Arm to Market Two Beigene Cancer Drugs in India | MT |
May. 14 | BeiGene Highlights New Hematology Portfolio and Pipeline Data at EHA2024 | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
17.56B | - | |||||
115B | ||||||
106B | ||||||
24.69B | - | |||||
21.97B | - | |||||
19.27B |
- Stock Market
- Equities
- BGNE Stock
- Charts BeiGene, Ltd.
- Sector Chart